Omeros Corp SEC filings OMER
Omeros Corp has 810 filings in SEC EDGAR's recent list, going back to Mar 31, 2004. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 30, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 18, 2026 |
| DEF 14A | Proxy statement | May 30, 2025 | Jun 27, 2025 |
| DEF 14A | Proxy statement | Apr 29, 2024 | Jun 6, 2024 |
| DEF 14A | Proxy statement | May 17, 2023 | Jun 23, 2023 |
| DEF 14A | Proxy statement | May 2, 2022 | Jun 17, 2022 |
| DEF 14A | Proxy statement | Apr 30, 2021 | Jun 11, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2020 | — |
| DEF 14A | Proxy statement | Apr 29, 2020 | Jun 5, 2020 |
| DEF 14A | Proxy statement | Apr 29, 2019 | Jun 7, 2019 |
| DEF 14A | Proxy statement | Apr 30, 2018 | Jun 15, 2018 |
| DEF 14A | Proxy statement | Apr 25, 2017 | Jun 16, 2017 |
| DEF 14A | Proxy statement | Apr 22, 2016 | Jun 9, 2016 |
| DEF 14A | Proxy statement | Apr 23, 2015 | May 22, 2015 |
| DEF 14A | Proxy statement | Apr 24, 2014 | May 23, 2014 |
| DEF 14A | Proxy statement | Apr 24, 2013 | May 24, 2013 |
| DEF 14A | Proxy statement | Apr 27, 2012 | Jun 1, 2012 |
| DEF 14A | Proxy statement | Apr 27, 2011 | May 27, 2011 |
| DEF 14A | Proxy statement | Apr 28, 2010 | May 28, 2010 |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- OMER (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- WA
- Headquarters
- Seattle, WA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1285819
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.